These benefits, together with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assistance the strategy of concentrating on ACKR3 as a unique strategy to modulate the opioid method, which could open up new therapeutic avenues for opioid-linked Conditions.(2) The physician has been given a